38.19
0.35 (0.92%)
Previous Close | 37.84 |
Open | 38.26 |
Volume | 18,694 |
Avg. Volume (3M) | 58,916 |
Market Cap | 207,639,024 |
Price / Sales | 0.530 |
Price / Book | 2.85 |
52 Weeks Range | |
Earnings Date | 7 Nov 2024 |
Profit Margin | -14.09% |
Operating Margin (TTM) | 12.80% |
Diluted EPS (TTM) | -9.18 |
Quarterly Revenue Growth (YOY) | 25.60% |
Total Debt/Equity (MRQ) | 380.10% |
Current Ratio (MRQ) | 1.77 |
Operating Cash Flow (TTM) | 21.32 M |
Levered Free Cash Flow (TTM) | 23.91 M |
Return on Assets (TTM) | 3.76% |
Return on Equity (TTM) | -35.10% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Care Facilities (US) | Mixed | Bullish |
Medical Care Facilities (Global) | Mixed | Bullish | |
Stock | Nutex Health Inc. | Bullish | Bearish |
AIStockmoo Score
Analyst Consensus | 3.0 |
Insider Activity | NA |
Price Volatility | -5.0 |
Technical Moving Averages | 0.0 |
Technical Oscillators | -0.5 |
Average | -0.63 |
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers. |
|
Sector | Healthcare |
Industry | Medical Care Facilities |
Investment Style | Small Value |
% Held by Insiders | 39.05% |
% Held by Institutions | 8.90% |
52 Weeks Range | ||
Price Target Range | ||
High | 60.00 (Benchmark, 57.11%) | Buy |
Median | 55.00 (44.02%) | |
Low | 50.00 (Maxim Group, 30.92%) | Buy |
Average | 55.00 (44.02%) | |
Total | 2 Buy | |
Avg. Price @ Call | 37.56 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Benchmark | 12 Nov 2024 | 60.00 (57.11%) | Buy | 37.56 |
Maxim Group | 12 Nov 2024 | 50.00 (30.92%) | Buy | 37.56 |
No data within this time range.
Date | Type | Details |
---|---|---|
18 Nov 2024 | Announcement | NUTEX HEALTH OPENS MILWAUKEE ER & HOSPITAL, ITS SECOND LOCATION IN WISCONSIN |
07 Nov 2024 | Announcement | NUTEX HEALTH REPORTS THIRD QUARTER AND YEAR TO DATE SEPTEMBER 30, 2024 FINANCIAL RESULTS |
01 Nov 2024 | Announcement | NUTEX HEALTH SCHEDULES 2024 THIRD QUARTER FINANCIAL RESULTS RELEASE AND CONFERENCE CALL |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |